Bin-tao Huang
No.1 Tongdao North Street
Hohhot, 010050, China
Hohhot, 010050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
High CD163+CD206+ macrophage infiltration in the bone marrow microenvironment of newly diagnosed multiple myeloma patients.
Journal: Journal of leukocyte biology
Published: September 25, 2025
The Relationship Between Serum CysC, β2-MG and the Efficacy of Demethylation Therapy in Patients with Acute Myeloid leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 27, 2024
The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis.
Journal: Arthritis research & therapy
Published: April 17, 2020
Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines.
Journal: Leukemia research
Published: August 08, 2017
EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins.
Journal: International journal of medical sciences
Published: January 16, 2016
Decitabine plus thalidomide yields more sustained survival rates than decitabine monotherapy for risk-tailored elderly patients with myelodysplastic syndrome.
Journal: Leukemia research
Published: November 23, 2014
A prospective, observational study of added medium-dose cytosine arabinoside versus As2O3 for elderly patients with acute promyelocytic leukemia.
Journal: Medical oncology (Northwood, London, England)
Published: July 17, 2014
How to determine post-FCR therapy for cytogenetic risk-tailored elderly patients with chronic lymphocytic leukemia, maintenance rituximab or observation.
Journal: Medical oncology (Northwood, London, England)
Published: May 22, 2014
Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation.
Journal: Leukemia research
Published: May 08, 2014
Standard intensive chemotherapy is less effective and far more toxic than attenuated induction and post-induction regimen in elderly patients with acute myeloid leukemia.
Journal: Medical oncology (Northwood, London, England)
Published: March 13, 2014
How to determine bortezomib-based regimen for elderly patients with multiple myeloma: PAD versus CBd, an observational study.
Journal: Journal of cancer research and clinical oncology
Published: November 19, 2013
Homoharringtonine contributes to imatinib sensitivity by blocking the EphB4/RhoA pathway in chronic myeloid leukemia cell lines.
Journal: Medical oncology (Northwood, London, England)
Published: October 31, 2013
Last Updated: 09/26/2026